PVLA — Palvella Therapeutics, Inc. | XLV Holdings | StockAdder

(PVLA)

Palvella Therapeutics, Inc.

Live chart and latest PVLA stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

PVLA News

Palvella Therapeutics (PVLA) price target increased by 15.78% to 224.97

Apr 11, 2026 Yahoo Finance

Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Mar 2, 2026 Stock Titan

Palvella lines up 3 rare-disease trials after $230M financing

Mar 31, 2026 Quiver Quantitative

Palvella Therapeutics, Inc. Announces $200 Million Upsized Public Offering of Common Stock

Feb 26, 2026 simplywall.st

Has Palvella Therapeutics (PVLA) Run Too Far After Its 334% One-Year Surge?

Mar 26, 2026 Sahm

Palvella Hire Highlights QTORIN Launch Plans And Deep Rare Skin Focus

Mar 31, 2026 Investing.com

Palvella Therapeutics stock hits 52-week high at 115.95 USD

Feb 24, 2026 Trefis

Palvella (PVLA) Stock Pre-Market (+13%): Phase 3 Topline Data Anticipation

Feb 24, 2026 Seeking Alpha

Palvella Therapeutics: A Potential First-In-Class Therapy In A Rare Dermatology Market

Mar 17, 2026 Investor's Business Daily

Why Top 2% Palvella Therapeutics, Up 33%, Just Blew Past Its 50-Day Line

Feb 24, 2026 Quiver Quantitative

PALVELLA THERAPEUTICS ($PVLA) Releases Q4 2025 Earnings, Stock Rises

Mar 31, 2026 Yahoo Finance

High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin

Dec 21, 2025 Stock Titan

Palvella (NASDAQ: PVLA) wins Phase 3 QTORIN data and $230M raise

Mar 31, 2026 Yahoo Finance

Palvella Therapeutics (NASDAQ:PVLA) Is In A Good Position To Deliver On Growth Plans

Nov 12, 2025 Quiver Quantitative

Palvella Therapeutics Closes $230 Million Upsized Public Offering of Common Stock